News

Lithium Americas resumed with an Outperform at Evercore ISI
Evercore ISI resumed coverage of Lithium Americas (LAC) with an Outperform rating with a price target of $4.50, down from $9. This lithium ...
The Trump tariff deals could be hard to reach, says Evercore ISI's Sarah Bianchi
Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss the Trump administration's tariff ...
Evercore ISI Sticks to Its Buy Rating for Alnylam Pharma (ALNY)
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...
Taking chips off the table in the defensive sectors, says Evercore ISI's Julian Emanuel
Julian Emanuel, Evercore ISI senior managing director, joins 'Closing Bell Overtime' to talk tariffs, corporate uncertainty, ...
Fierce Pharma1d
BMS growth driver Camzyos fails in heart disease trial, denting expansion opportunity
Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...
The collapse of dollar shows 'the biggest damage right now is to the U.S. brand'
The mighty dollar, ordinarily a safe haven during times of market-based stress, is falling apart, and its ongoing year-to-date slide is pointing to a much bigger problem for all U.S. assets.
Five Below, Lucid Group, Verizon: Market Minute
Julie Hyman goes over some of Friday's top stories on this segment of Market Minute. Five Below (FIVE) stock is under ...